Sign Up
Stories
Parkinson's Disease Epidemiology Forecast
Share
ABVC BioPharma's Patent and Partnership
ADvantage Therapeutics Appoints Professo...
ALS Treatment Withdrawal: FDA Concerns
Innovative GI Drug Data Revealed
Innovative Ibogaine Experiment Led by Dr...
Rituximab Biosimilars Market Growth
Overview
API
The 'Parkinson's Disease - Epidemiology Forecast - 2032' report delves into the historical and forecasted epidemiology of Parkinson's disease in various regions, including the United States, EU4, the UK, and Japan. It emphasizes the progressive nature of the disorder, caused by nerve cell degeneration in the substantia nigra, affecting movement. Additionally, it highlights the diagnostic processes and the use of neuroimaging studies to distinguish Parkinson's disease from other parkinsonian disorders.
Ask a question
How might advancements in neuroimaging studies impact the diagnosis and treatment of Parkinson's disease?
In what ways could the epidemiology of Parkinson's disease influence the development of new therapies and treatment approaches?
What are the potential implications of the forecasted epidemiology of Parkinson's disease on healthcare systems and policy decisions?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage